1182 related articles for article (PubMed ID: 18436819)
1. A rabbit dry eye model induced by topical medication of a preservative benzalkonium chloride.
Xiong C; Chen D; Liu J; Liu B; Li N; Zhou Y; Liang X; Ma P; Ye C; Ge J; Wang Z
Invest Ophthalmol Vis Sci; 2008 May; 49(5):1850-6. PubMed ID: 18436819
[TBL] [Abstract][Full Text] [Related]
2. Research on the stability of a rabbit dry eye model induced by topical application of the preservative benzalkonium chloride.
Li C; Song Y; Luan S; Wan P; Li N; Tang J; Han Y; Xiong C; Wang Z
PLoS One; 2012; 7(3):e33688. PubMed ID: 22438984
[TBL] [Abstract][Full Text] [Related]
3. Sodium hyaluronate decreases ocular surface toxicity induced by benzalkonium chloride-preserved latanoprost: an in vivo study.
Yu F; Liu X; Zhong Y; Guo X; Li M; Mao Z; Xiao H; Yang S
Invest Ophthalmol Vis Sci; 2013 May; 54(5):3385-93. PubMed ID: 23620425
[TBL] [Abstract][Full Text] [Related]
4. Effects of sequential artificial tear and cyclosporine emulsion therapy on conjunctival goblet cell density and transforming growth factor-beta2 production.
Pflugfelder SC; De Paiva CS; Villarreal AL; Stern ME
Cornea; 2008 Jan; 27(1):64-9. PubMed ID: 18245969
[TBL] [Abstract][Full Text] [Related]
5. Ocular surface and tear functions after topical cyclosporine treatment in dry eye patients with chronic graft-versus-host disease.
Wang Y; Ogawa Y; Dogru M; Kawai M; Tatematsu Y; Uchino M; Okada N; Igarashi A; Kujira A; Fujishima H; Okamoto S; Shimazaki J; Tsubota K
Bone Marrow Transplant; 2008 Feb; 41(3):293-302. PubMed ID: 17982500
[TBL] [Abstract][Full Text] [Related]
6. Effects of Topical Mucolytic Agents on the Tears and Ocular Surface: A Plausible Animal Model of Mucin-Deficient Dry Eye.
Li X; Kang B; Woo IH; Eom Y; Lee HK; Kim HM; Song JS
Invest Ophthalmol Vis Sci; 2018 Jun; 59(7):3104-3114. PubMed ID: 30025127
[TBL] [Abstract][Full Text] [Related]
7. Reduced in vivo ocular surface toxicity with polyquad-preserved travoprost versus benzalkonium-preserved travoprost or latanoprost ophthalmic solutions.
Liang H; Brignole-Baudouin F; Riancho L; Baudouin C
Ophthalmic Res; 2012; 48(2):89-101. PubMed ID: 22473057
[TBL] [Abstract][Full Text] [Related]
8. Effects of topical cyclosporine a plus artificial tears versus artificial tears treatment on conjunctival goblet cell density in dysfunctional tear syndrome.
Demiryay E; Yaylali V; Cetin EN; Yildirim C
Eye Contact Lens; 2011 Sep; 37(5):312-5. PubMed ID: 21792057
[TBL] [Abstract][Full Text] [Related]
9. Comparison of toxicological profiles of benzalkonium chloride and polyquaternium-1: an experimental study.
Labbé A; Pauly A; Liang H; Brignole-Baudouin F; Martin C; Warnet JM; Baudouin C
J Ocul Pharmacol Ther; 2006 Aug; 22(4):267-78. PubMed ID: 16910868
[TBL] [Abstract][Full Text] [Related]
10. [Protection effect of sodium hyaluronate on ocular surface toxicity induced by Benzalkonium chloride-preserved brimonidine in rabbits].
Yu FF; Liu X; Zhong YM; Mao Z; Guo XX; Li M; Cao D; Chen XX
Zhonghua Yan Ke Za Zhi; 2013 Nov; 49(11):973-80. PubMed ID: 24512997
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic effects of epidermal growth factor on benzalkonium chloride-induced dry eye in a mouse model.
Xiao X; He H; Lin Z; Luo P; He H; Zhou T; Zhou Y; Liu Z
Invest Ophthalmol Vis Sci; 2012 Jan; 53(1):191-7. PubMed ID: 22159022
[TBL] [Abstract][Full Text] [Related]
12. Comparison of corneal and conjunctival changes after dosing of travoprost preserved with sofZia, latanoprost with 0.02% benzalkonium chloride, and preservative-free artificial tears.
Kahook MY; Noecker RJ
Cornea; 2008 Apr; 27(3):339-43. PubMed ID: 18362664
[TBL] [Abstract][Full Text] [Related]
13. Effects of benzalkonium chloride on the ocular surface of the rabbit.
Kim JR; Oh TH; Kim HS
Jpn J Ophthalmol; 2011 May; 55(3):283-293. PubMed ID: 21537998
[TBL] [Abstract][Full Text] [Related]
14. Corneal alternations induced by topical application of benzalkonium chloride in rabbit.
Chen W; Li Z; Hu J; Zhang Z; Chen L; Chen Y; Liu Z
PLoS One; 2011; 6(10):e26103. PubMed ID: 22022526
[TBL] [Abstract][Full Text] [Related]
15. Quantitative analysis of conjunctival goblet cells after chronic application of topical drops.
Kahook MY; Noecker R
Adv Ther; 2008 Aug; 25(8):743-51. PubMed ID: 18670744
[TBL] [Abstract][Full Text] [Related]
16. Ocular surface and MUC5AC alterations in atopic patients with corneal shield ulcers.
Dogru M; Asano-Kato N; Tanaka M; Igarashi A; Shimmura S; Shimazaki J; Okada N; Takano Y; Fukagawa K; Tsubota K; Fujishima H
Curr Eye Res; 2005 Oct; 30(10):897-908. PubMed ID: 16251127
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic effects of topical doxycycline in a benzalkonium chloride-induced mouse dry eye model.
Zhang Z; Yang WZ; Zhu ZZ; Hu QQ; Chen YF; He H; Chen YX; Liu ZG
Invest Ophthalmol Vis Sci; 2014 May; 55(5):2963-74. PubMed ID: 24722696
[TBL] [Abstract][Full Text] [Related]
18. New tools for the evaluation of toxic ocular surface changes in the rat.
Pauly A; Brignole-Baudouin F; Labbé A; Liang H; Warnet JM; Baudouin C
Invest Ophthalmol Vis Sci; 2007 Dec; 48(12):5473-83. PubMed ID: 18055795
[TBL] [Abstract][Full Text] [Related]
19. [Therapeutic effects of Pyranoprofen on the mouse dry eye induced by topical medication of Benzalkonium Chloride].
He H; Liu ZG; Lin ZR; Liu XC; He H; Xiao QG
Zhonghua Yan Ke Za Zhi; 2012 Jan; 48(1):33-40. PubMed ID: 22490914
[TBL] [Abstract][Full Text] [Related]
20. [The effects of hyperosmotic stress on rabbit ocular surface and mucin 5AC expression].
Cai RR; Wang Y; Xu JJ; Zhang CR
Zhonghua Yan Ke Za Zhi; 2011 Mar; 47(3):252-9. PubMed ID: 21609628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
